A new, cheaper and faster anti-covid test is being developed to diagnose Sars Cov2, including the new Delta variant. The scientific results of the experimental phase have been published in the journal Nature Communication and are the result of research by a team of researchers from Stockholm Karolisnka University and Candiolo University in Turin.
The new test gives the results in real time and this is its great advantage, but it will also serve for the mapping of the tumor genome.
His name is Covseq and according to the doctors who with the authorization of the Italian authorities are testing him, it makes possible the sequencing of hundreds of viral samples per week, and at a cost below 15 Euros, which is more reduced than the methodologies currently used.